Long-term Results of Thoracoscopic Thymectomy for Thymoma without Myasthenia Gravis

Chung, JW; Hr, Kim; Dk, Kim; Chun, Chun; Yh, Kim; Park, Sung Ik; Kim, S-R; Dh, Lee

doi:10.1177/030006051204000539

Cited by 17 publications

(9 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…5 However, several recent studies reported survival and recurrence data for up to 10 years after VATS thymectomy. [20][21][22] 22 In this study, we reviewed our 13-year experience of the surgical treatment of stage I and II thymoma, and found similar outcomes to those reported in larger series. 20,21 The intermediate-term oncologic outcomes were as favorable as the outcomes after open thymectomy, supporting the feasibility of VATS thymectomy for the treatment of noninvasive thymoma.…”

Section: Discussion Oncologic Outcomessupporting

confidence: 64%

Intermediate-term oncologic outcomes after video-assisted thoracoscopic thymectomy for early-stage thymoma

Sakamaki

Oda

Kanazawa

et al. 2014

The Journal of Thoracic and Cardiovascular Surgery

View full text Add to dashboard Cite

show abstract

Section: Discussion Oncologic Outcomessupporting

confidence: 64%

Intermediate-term oncologic outcomes after video-assisted thoracoscopic thymectomy for early-stage thymoma

Sakamaki

Oda

Kanazawa

et al. 2014

The Journal of Thoracic and Cardiovascular Surgery

View full text Add to dashboard Cite

show abstract

“…[14][15][16] Several recent studies have reported recurrence and survival data up to 7 years after VATS thymectomy and conclude that recurrence-free and overall survivals are similar to those after open thymectomy. 6,[24][25][26] While we recognize that most recurrent disease occurs within 5 to 10 years of the primary resection, we did assess factors that may be surrogate measures of oncologic efficacy, which may affect long-term oncologic outcomes. These included R0/R1 resection, extent of thymectomy, ability to resect involved structures and adjuvant radiation therapy rates.…”

Section: Discussionmentioning

confidence: 99%

Robotic Resection of 3 Cm and Larger Thymomas is Associated with Low Perioperative Morbidity and Mortality

Wilshire¹,

Vallières²,

Shultz³

et al. 2016

Innovations�(Phila)

View full text Add to dashboard Cite

Objective The approach to thymoma resection has usually been determined by tumor size, although established guidelines do not exist. Minimally invasive approaches have been limited to tumors smaller than 5 cm, although 3 cm has been the suggested cutoff for performing an adequate oncologic procedure. No study has compared the perioperative outcomes of patients with 3 cm or larger tumors resected robotically versus sternotomy. Methods We reviewed patients who underwent resection of 3 cm or larger thymomas from 2004 to 2014. Patients were divided based on approach: robotic and open thymectomy/thymomectomy. Results Forty patients with tumors ranging from 3 to 13 cm were evaluated, 23 robotic and 17 open. Patient and tumor characteristics were similar. An R0 resection was primarily achieved: robotic, 91% (21/23); and open, 88% (15/17); P = 0.832. Adjuvant radiation rates were statistically equivalent: robotic, 17% (4/23) versus open, 41% (7/17); P = 0.191. Major postoperative complications were comparable: robotic, 4% (1/23) versus open, 29% (4/17); P = 0.184. Median chest tube duration was shorter for robotic (1 day) versus open (3 days); P = 0.001. The robotic approach had a shorter median intensive care unit stay compared to open (0 days vs 1day); P = 0.024. The median hospital stay was shorter for robotic (2 days) versus open (5 days); P < 0.001. Conclusions In 3 cm or larger thymomas, robotic thymectomy is feasible based on the ability to achieve a complete resection with similar adjuvant radiation therapy rates. Perioperatively, robotic thymectomy is associated with lower morbidity; and shorter chest tube duration, intensive care unit stay, and hospital stay compared to open. However, on-cologic outcomes are immature and require prolonged surveillance.

show abstract

“…Using the modified Masaoka staging system, Agasthian and colleagues 10 suggested that early-stage thymomas can be safely resected with VATS; but 13 invasive thymomas were also successfully resected with VATS, with modifications in the technique, without resorting to sternotomy. A study by Chung and colleagues 11 on 25 patients undergoing thoracoscopic thymectomy for thymoma without MG, showed that none of the patients had Masaoka stage III, and only one had Masaoka stage IV disease. Similarly, our data showed that only 2 (3.8%) thymomas were stage III.…”

Section: Discussionmentioning

confidence: 99%

Video-assisted thoracoscopic thymectomy for thymoma: a single-center experience

Nguyêñ

Nguyen

et al. 2018

Asian Cardiovasc Thorac Ann

View full text Add to dashboard Cite

Background Thymoma is a primary tumor derived from the epithelial cells of the thymus, which is commonly seen in the mediastinum. Surgical thymectomy is the radical treatment for thymoma. The recent introduction of video-assisted thoracoscopic surgery has improved the quality of thymectomy surgery. The clinical characteristics of thymoma and the outcomes of video-assisted thoracoscopic thymectomy in Vietnamese patients are still lacking. The objectives of this study were to investigate the clinical and laboratory characteristics of thymoma and to evaluate the early results of video-assisted thoracoscopic thymectomy for thymoma in Vietnamese patients. Methods All 53 thymoma patients with or without myasthenia gravis who underwent video-assisted thoracoscopic thymectomy in Military Hospital 103, Vietnam, from October 2013 to July 2017 were included. Results The mean age was 46.5 7.1 years, and the female/male ratio was 1.2:1. Myasthenia gravis, mostly stage IIA, was present in 84.9% of patients. There was no hospital mortality or major postoperative complication. The mean operative time was 65 min, intensive care unit stay was 22 ± 5 h, and postoperative hospital stay was 7.5 ± 1.7 days. Conclusion Thoracoscopic thymectomy for thymoma in Vietnamese patients achieved improved cosmesis and was safe for both non-myasthenia gravis and myasthenia gravis patients.

show abstract

Long-term Results of Thoracoscopic Thymectomy for Thymoma without Myasthenia Gravis

Cited by 17 publications

References 22 publications

Intermediate-term oncologic outcomes after video-assisted thoracoscopic thymectomy for early-stage thymoma

Intermediate-term oncologic outcomes after video-assisted thoracoscopic thymectomy for early-stage thymoma

Robotic Resection of 3 Cm and Larger Thymomas is Associated with Low Perioperative Morbidity and Mortality

Video-assisted thoracoscopic thymectomy for thymoma: a single-center experience

Contact Info

Product

Resources

About